Von dem Buch Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment: Frontiers of Gastrointestinal Research 28 haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: A.L. Gerbes: Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment: Frontiers of Gastrointestinal Research 28 (ISBN: 9783805595926) 2010, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
39%: Gerbes, A. L. (Editor)/ Wilcox, C. Mel (Editor)/ Munoz-navas, Miguel (Editor): Ascites Hyponatremia and Hepatorenal Syndrome: Progress in Treatment (Frontiers of Gastrointestinal Research) (ISBN: 9783805595919) 2010, S Karger Pub, Erstausgabe, in Deutsch, Broschiert.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment: Frontiers of Gastrointestinal Research 28
13 Angebote vergleichen
| Preise | 2013 | 2014 | 2018 | 2019 |
|---|---|---|---|---|
| Schnitt | € 135,00 | € 135,00 | € 216,58 | € 231,84 |
| Nachfrage |
1
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment (2010)
EN NW EB DLISBN: 9783805595926 bzw. 3805595921, in Englisch, S. Karger, S. Karger, S. Karger, neu, E-Book, elektronischer Download.
Lieferung aus: Kanada, in-stock.
Ascites is the most frequent and hepatorenal syndrome the most lethal complication in liver cirrhosis. In recent years, major progress has been made regarding effective treatment of these complications, thus reducing mortality in patients. This publication highlights and critically appraises recent achievements and novel advances, and at the same time provides the background needed to grasp novel concepts. Topics treated include complications of paracentesis, the right choice of plasma expanders, and selection of patients who will experience survival benefit from transjugular intrahepatic portosystemic shunt. Hepatorenal syndrome, on the other hand, is responsible for a broad spectrum of manifestations caused by acute kidney injury, which until recently was considered a lethal condition. Drug treatments to improve renal function and prolong survival are therefore also discussed, including important issues for clinical outcome which are still under debate. Moreover, the role of combined kidney-liver transplantation versus conventional liver-only transplantation is addressed, as well as the use of vaptans in hyponatremia and their controversial role in the treatment of ascites. Renowned experts share their knowledge and expertise and provide an international perspective. Their contributions include up-to-date references and a bullet-point summary, making this publication most valuable for practitioners, clinicians and scientists in the field.
Ascites is the most frequent and hepatorenal syndrome the most lethal complication in liver cirrhosis. In recent years, major progress has been made regarding effective treatment of these complications, thus reducing mortality in patients. This publication highlights and critically appraises recent achievements and novel advances, and at the same time provides the background needed to grasp novel concepts. Topics treated include complications of paracentesis, the right choice of plasma expanders, and selection of patients who will experience survival benefit from transjugular intrahepatic portosystemic shunt. Hepatorenal syndrome, on the other hand, is responsible for a broad spectrum of manifestations caused by acute kidney injury, which until recently was considered a lethal condition. Drug treatments to improve renal function and prolong survival are therefore also discussed, including important issues for clinical outcome which are still under debate. Moreover, the role of combined kidney-liver transplantation versus conventional liver-only transplantation is addressed, as well as the use of vaptans in hyponatremia and their controversial role in the treatment of ascites. Renowned experts share their knowledge and expertise and provide an international perspective. Their contributions include up-to-date references and a bullet-point summary, making this publication most valuable for practitioners, clinicians and scientists in the field.
2
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment
~EN NW EB DLISBN: 9783805595926 bzw. 3805595921, vermutlich in Englisch, S. Karger, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment: Ascites is the most frequent and hepatorenal syndrome the most lethal complication in liver cirrhosis. In recent years, major progress has been made regarding effective treatment of these complications, thus reducing mortality in patients. This publication highlights and critically appraises recent achievements and novel advances, and at the same time provides the background needed to grasp novel concepts. Topics treated include complications of paracentesis, the right choice of plasma expanders, and selection of patients who will experience survival benefit from transjugular intrahepatic portosystemic shunt. Hepatorenal syndrome, on the other hand, is responsible for a broad spectrum of manifestations caused by acute kidney injury, which until recently was considered a lethal condition. Drug treatments to improve renal function and prolong survival are therefore also discussed, including important issues for clinical outcome which are still under debate. Moreover, the role of combined kidney-liver transplantation versus conventional liver-only transplantation is addressed, as well as the use of vaptans in hyponatremia and their controversial role in the treatment of ascites. Renowned experts share their knowledge and expertise and provide an international perspective. Their contributions include up-to-date references and a bullet-point summary, making this publication most valuable for practitioners, clinicians and scientists in the field. Englisch, Ebook.
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment: Ascites is the most frequent and hepatorenal syndrome the most lethal complication in liver cirrhosis. In recent years, major progress has been made regarding effective treatment of these complications, thus reducing mortality in patients. This publication highlights and critically appraises recent achievements and novel advances, and at the same time provides the background needed to grasp novel concepts. Topics treated include complications of paracentesis, the right choice of plasma expanders, and selection of patients who will experience survival benefit from transjugular intrahepatic portosystemic shunt. Hepatorenal syndrome, on the other hand, is responsible for a broad spectrum of manifestations caused by acute kidney injury, which until recently was considered a lethal condition. Drug treatments to improve renal function and prolong survival are therefore also discussed, including important issues for clinical outcome which are still under debate. Moreover, the role of combined kidney-liver transplantation versus conventional liver-only transplantation is addressed, as well as the use of vaptans in hyponatremia and their controversial role in the treatment of ascites. Renowned experts share their knowledge and expertise and provide an international perspective. Their contributions include up-to-date references and a bullet-point summary, making this publication most valuable for practitioners, clinicians and scientists in the field. Englisch, Ebook.
4
Ascites Hyponatremia and Hepatorenal Syndrome: Progress in Treatment (2010)
DE HC NW FEISBN: 9783805595919 bzw. 3805595913, in Deutsch, S Karger Pub, gebundenes Buch, neu, Erstausgabe.
Von Händler/Antiquariat, Revaluation Books [2134736], Exeter, United Kingdom.
1st edition. 212 pages. 10.16x7.56x0.63 inches. In Stock.
1st edition. 212 pages. 10.16x7.56x0.63 inches. In Stock.
5
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment
~EN PB NWISBN: 9783805595926 bzw. 3805595921, vermutlich in Englisch, Karger, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment
DE NWISBN: 9783805595926 bzw. 3805595921, in Deutsch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment als eBook von
DE NWISBN: 9783805595926 bzw. 3805595921, in Deutsch, Karger, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment
~EN NW EB DLISBN: 9783805595926 bzw. 3805595921, vermutlich in Englisch, neu, E-Book, elektronischer Download.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Ascites Hyponatremia and Hepatorenal Syndrome: Progress in Treatment (Frontiers of Gastrointestinal Research) (2010)
DE HC USISBN: 9783805595919 bzw. 3805595913, in Deutsch, S Karger Pub, gebundenes Buch, gebraucht.
Von Händler/Antiquariat, HPB-Dallas [54223947], Dallas, TX, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment: Frontiers of Gastrointestinal Research 28
~EN NW EBISBN: 9783805595926 bzw. 3805595921, vermutlich in Englisch, Karger, S. Inc. neu, E-Book.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…